𝔖 Bobbio Scriptorium

✦ LIBER ✦

Hospital Waste Treatment and Disposal in the General University Hospital - Current Situation and Future Challenges

✍ Scribed by Bencko, V.; Kapek, J.; Vinš, O.

Book ID: 126641918
Publisher: SAGE Publications
Year: 2003
Tongue: English
Weight: 120 KB
Volume: 12
Category: Article
ISSN: 1420-326X
DOI: 10.1177/1420326X03012001016

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The Psychiatric Unit in a General Hospit

The Psychiatric Unit in a General Hospital: Its Current and Future Role

✍ Schwab, John J. 📂 Article 📅 1967 🏛 American Psychiatric Publishing Inc 🌐 English ⚖ 355 KB

Current approaches in the treatment of b

Current approaches in the treatment of bladder cancer and policy in Marmara University Hospital

✍ D. Ersev; Y. Ilker; F. Simşek; A. Akdas 📂 Article 📅 1990 🏛 Springer Netherlands 🌐 English ⚖ 313 KB

Supplement 1: Colorectal Cancer and its

Supplement 1: Colorectal Cancer and its Burden: Prevention, Treatment and Access to Care || Colorectal cancer in Turkey: current situation and challenges for the future

✍ Mehtap Tatar and Fahreddin Tatar 📂 Article 📅 2010 🏛 Springer 🌐 French ⚖ 1010 KB

P311 Azathioprine and allopurinol co-the

P311 Azathioprine and allopurinol co-therapy for IBD patients is a safe and effective treatment option in the district general hospital setting

✍ H. Johnson; S.A. Weaver; S. Mclaughlin 📂 Article 📅 2012 🏛 Oxford University Press 🌐 English ⚖ 61 KB

Fiftieth Anniversary Celebration, Social

Fiftieth Anniversary Celebration, Social Service Department, Massachusetts General Hospital: Selected Papers and Reports;Fifty Years of Social Work in the Medical Setting: Past Significance/Future Outlookby Harriett M. Bartlett

✍ Review by: Katherine Hagberg 📂 Article 📅 1959 🏛 University of Chicago Press 🌐 English ⚖ 499 KB

40 kDa peginterferon alfa-2A (PEGASYS®):

40 kDa peginterferon alfa-2A (PEGASYS®): efficacy and safety results from a phase II, randomized, actively controlled, multicenter study in the treatment of HBeAg positive chronic hepatitis B: Graham E Cooksley, Royal Brisbane Hospital, Herston, Queensland Australia; Teerha Piratvisuth, Songklanakarin Hospital, Songkla Thailand; Yuan-Jen Wang, Teipei Veterans General Hospital, Taipei Taiwan; Varocha Mahachai, Chulalongkorn Hospital, Bangkok Thailand; You-Chen Chao, Tri Service General Hosptital, Taipei Taiwan; Tawesak Tanwandee, Siriraj Hospital, Bangkok Thailand; Anuchit Chutaputti, Pramongkutklao Hospital, Bangkok Thailand; Wen Yu Chang, Kaohsiung University Hospital, Kaohsiung Taiwan; Friederike E Zahm, Hoffmann-La Roche Basel Switzerland; Nigel Pluck, Roche Products Ltd, Welwyn Uk

📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 228 KB